The Nebraska Cancer Research Center
Since 1984, The Nebraska Cancer Research Center has been a leader in cancer research, providing local access to National Cancer Institute-sponsored cancer clinical trials. Over 1,900 volunteers have participated in treatment, prevention and control trials through NCRC, helping to identify more effective cancer treatments and improve the quality of life of cancer patients.
CONGRATS to Sandi Hansen - Winner of the raffle for the 2013 Mercedes Benz C250 Sport!!
- Posted on 06/04/2014
- Posted on 05/21/2014
- Posted on 02/21/2014
WHAT IS A CLINICAL TRIAL?
New Clinical TrialsView all clinical trials available at NCRC.
ECOG-ACRIN E4512: Non-Small Cell Lung Cancer - A Phase III Double-Blind Trial for Surgically Resected Early Stage Non-Small Cell Lung Cancer: Crizotinib versus Placebo for Patients with Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein
ACCRU RU021212I: Esophageal Cancer - Randomized Phase II Double Blind Study of Adjuvant Regorafenib vs Placebo in Patients with Node Positive Esophageal Cancer that Completed Pre-operative Therapy
GOG 3004: A Phase III, Randomised, Double Blind, Placebo Controlled, Multicentre Study of Olaparib Maintenance Monotherapy in Patients with BRCA Mutated Advanced (FIGO Stage III-IV) Ovarian Cancer following First Line Platinum Based Chemotherapy.
S1400: Squamous Cell Lung Cancer - Phase II/III Biomarker-Driven Master Protocol for Second Line Therapy of Squamous Cell Lung Cancer.